HomeTeleflex Incorporated

Teleflex Incorporated

Data Suggest That Men Should Resolve to Address Their BPH Symptoms in 2019

1/16/19: “Data clearly show that both men and women have significant misconceptions about men’s health, including BPH and the ways to treat the condition,” said Ana Fadich, vice president of Men’s Health Network.

NeoTract’s UroLift® System 12-Month MedLift Study Published in Prostate Cancer and Prostatic Diseases

The MedLift Study provided clinical evidence to support the safety and efficacy of the UroLift System treatment for BPH, or an enlarged prostate, involving a median lobe obstruction.

Arrow Seldinger Arterial Catheterization Device Receives FDA Market Clearance

Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, has announced today that its Arrow Seldinger Arterial Catheterization Device received market clearance from the U.S. Food and Drug Administration (FDA). The...

Teleflex to Showcase Key Anesthesia Products at Euroanaesthesia 2017 in Geneva

The company will showcase the LMA® Protector™ and other key products in its Anesthesia portfolio, together with its innovative Vascular Access platform, at the Euroanesthesia Congress in Geneva, Switzerland, June 3 – 5, 2017. Throughout ESA 2017, the...

Clearance for the Arrow® AC3 OptimusTM Intra-Aortic Balloon Pump (IABP)

Advanced IABP performance with the ability to provide optimized therapy to the most challenging patient conditions, even patients with the most severe arrhythmias and heart rates as high as 200 bpm.1 References: Schreuder J, Castiglioni A, Donelli A, et...